| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.3 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.3 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |